Literature DB >> 16298940

Studies on radiation-induced apoptosis in G0 human lymphocytes.

P Belloni1, R Meschini, S Czene, M Harms-Ringdahl, F Palitti.   

Abstract

PURPOSE: To determine the relationships between the frequencies of radiation-induced chromosomal alterations and the extent of apoptosis in G0 human lymphocytes.
MATERIAL AND METHODS: G0 human peripheral blood lymphocytes (HPBL) were X or gamma-irradiated, in the presence or absence of the repair inhibitor cytosine arabinoside (Ara-C). Directly after irradiation, a part of the lymphocytes were stimulated to grow while the rest were stimulated 48 h after irradiation. These lymphocyte cultures were analysed for induction of chromosomal aberrations. A subset of lymphocytes was kept in G0 and analysed for cell viability, apoptosis and p53 expression.
RESULTS: The fraction of cells bearing dicentrics was reduced in lymphocytes stimulated to grow 48 h post irradiation as compared to lymphocytes stimulated immediately after irradiation. The decrease in the frequency of dicentrics correlated with the increase in the number of apoptotic cells. The operative apoptotic pathway in irradiated Go lymphocytes was dependent on the expression of p53.
CONCLUSIONS: The radiation-induced apoptotic response of G0 lymphocytes is p53 dependent and increases with the time they are held in G0. When mitogen was added 48 h after irradiation, cells with dicentrics were either preferentially eliminated or did not enter mitosis. Thus the radiation-induced damage can be underevaluated depending on the time between radiation exposure and the induction of proliferation. These results may have relevance for biodosimetry studies or for evaluations of the efficacy of radiotherapy which are based on the frequencies of chromosomal aberrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298940     DOI: 10.1080/09553000500303690

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

1.  Palliative Care for Salivary Gland Dysfunction Highlights the Need for Regenerative Therapies: A Review on Radiation and Salivary Gland Stem Cells.

Authors:  Alejandro Martinez Chibly; Thao Nguyen; Kirsten H Limesand
Journal:  J Palliat Care Med       Date:  2014-08-06

2.  Bystander effect in tumor cells produced by Iodine-125 labeled human lymphocytes.

Authors:  Omar Mamlouk; Pichumani Balagurumoorthy; Ketai Wang; S James Adelstein; Amin I Kassis
Journal:  Int J Radiat Biol       Date:  2012-07-09       Impact factor: 2.694

3.  The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.

Authors:  T E Schmid; L Canella; P Kudejova; F M Wagner; A Röhrmoser; E Schmid
Journal:  Radiat Environ Biophys       Date:  2014-11-27       Impact factor: 1.925

4.  Transcriptional Dynamics of DNA Damage Responsive Genes in Circulating Leukocytes during Radiotherapy.

Authors:  Lourdes Cruz-Garcia; Farah Nasser; Grainne O'Brien; Jakub Grepl; Volodymyr Vinnikov; Viktor Starenkiy; Sergiy Artiukh; Svetlana Gramatiuk; Christophe Badie
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

5.  Induction and inhibition of the pan-nuclear gamma-H2AX response in resting human peripheral blood lymphocytes after X-ray irradiation.

Authors:  D Ding; Y Zhang; J Wang; X Zhang; Y Gao; L Yin; Q Li; J Li; H Chen
Journal:  Cell Death Discov       Date:  2016-03-21

6.  Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms?

Authors:  J Miszczyk; K Rawojć; A Panek; A Borkowska; P G S Prasanna; M M Ahmed; J Swakoń; A Gałaś
Journal:  Clin Transl Radiat Oncol       Date:  2018-01-31

7.  Development of a high-throughput γ-H2AX assay based on imaging flow cytometry.

Authors:  Younghyun Lee; Qi Wang; Igor Shuryak; David J Brenner; Helen C Turner
Journal:  Radiat Oncol       Date:  2019-08-22       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.